Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants - PubMed
4 hours ago
- #hematologic malignancy
- #network meta-analysis
- #diabetes medications
- This study is a network meta-analysis examining agent-specific and histopathology-stratified hematologic malignancy risks associated with DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors.
- The analysis includes data from 270,471 participants, providing a large-scale comparison of these diabetes medications in relation to hematologic cancers such as leukemia, lymphoma, and myeloma.
- The authors declare no competing interests and note that individual patient consent was not applicable due to the study's meta-analytic nature, which did not involve direct participant contact or data exploration.